CytomX

Recent news

• Rating change
  Barclays Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $16
  Market Newswire · 2026/3/19
• Rating change
  Oppenheimer Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $12
  Market Newswire · 2026/5/13
• Rating change
  Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $15
  Market Newswire · 2026/3/18
• Rating change
  Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $12
  Market Newswire · 2026/3/23
• Rating change
  Wolfe Research Initiates CytomX(CTMX.US) With Buy Rating, Announces Target Price $6
  Market Newswire · 2026/5/19
• Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $12
  Market Newswire · 2026/9/23
• Rating change
  H.C. Wainwright Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $11
  Market Newswire · 2026/5/11
• J.P. Morgan Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $11
  Market Newswire · 2026/8/17
• Rating change
  Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $10
  Market Newswire · 2026/2/26
• Rating change
  Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $15
  Market Newswire · 2026/5/8
• Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $16
  Market Newswire · 2026/8/7
• Rating change
  Oppenheimer Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $10
  Market Newswire · 2026/2/6
• J.P. Morgan Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $11
  Market Newswire · 2026/8/13
• Rating change
  Jefferies Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $16
  Market Newswire · 2026/3/18
• Rating change
  Barclays Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $10
  Market Newswire · 2026/2/4
• Rating change
  A Quick Look at Today's Ratings for CytomX(CTMX.US), With a Forecast Between $11 to $16
  Market Newswire · 2026/5/9
• Wedbush Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $11
  Market Newswire · 2026/6/4
• Rating change
  Cantor Fitzgerald Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $10
  Market Newswire · 2026/3/9
• Rating change
  Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $10
  Market Newswire · 2026/3/9
• Rating change
  A Quick Look at Today's Ratings for CytomX(CTMX.US), With a Forecast Between $10 to $17
  Market Newswire · 2026/3/17

Headlines are aggregated automatically and are not independently verified or edited by our team.